Another study demonstrated that nicotinamide-N-methyltransferase (NNMT), secretagogin, L-plastin, neuron specific enolase (NSE), NM23, ferritin light chain, and thioredoxin peroxidase were the candidate biomarkers that were elevated in RCC tumors [79]. The gene discussed is ENO2; the disease is renal cell carcinoma.